STAT+

Key FDA Infectious Disease Regulator Announces Departure WASHINGTON – A significant shift is occurring within the Food and Drug Administration as Adam …

The biopharmaceutical landscape is experiencing a significant shift in leadership, as Invivyd, a company focused on developing and commercializing innovative antibody therapies, …

Public Opinion Shifts: Trump Receives More Credit for Potential Drug Price Reductions WASHINGTON – The persistent challenge of lowering prescription drug costs …

Archyworldys.com delivers breaking news and in-depth analysis on the critical issues shaping healthcare today. A significant legal challenge is unfolding in Oregon, …

Vertex’s Promising IgA Nephropathy Drug Shows Significant Results in Phase 3 Trial In a significant advancement for the treatment of IgA nephropathy, …

Science Corporation Secures $230 Million Funding Amid FDA Review of Groundbreaking Retinal Implant Science Corporation, a pioneering biotechnology firm, announced today that …

Health Secretary Kennedy Jr. Targets Sugar Content in Popular Beverages AUSTIN, Texas – Health Secretary Robert F. Kennedy Jr. signaled a potential …

The boundaries of biological possibility are rapidly shifting as scientists achieve unprecedented fidelity in recreating the earliest stages of human development in …

FDA Chief Makary Defends Agency’s Rigorous Rare Disease Drug Review Process WASHINGTON – Food and Drug Administration Commissioner Robert Califf’s successor, Marty …

Novo Nordisk Cuts Drug Prices, But Will It Truly Expand Access? Novo Nordisk, a leading pharmaceutical company, announced a significant reduction in …